Koyfin Home > Directory > Health Care > Albireo Pharma Inc > EV / Sales (ltm)

Albireo Pharma Inc EV / Sales (ltm) Chart (ALBO)

Albireo Pharma Inc annual/quarterly EV / Sales (ltm) from 2016 to 2020.
  • Albireo Pharma Inc EV / Sales (ltm) for the quarter ending September 09, 2020 was 51.12 a -7.31% decrease of -3.74 year over year
  • Albireo Pharma Inc EV / Sales (ltm) for the last 12 months ending September 09, 2020 was 51.12 a -7.31% decrease of -3.74 year over year
  • Albireo Pharma Inc Annual EV / Sales (ltm) for 2020 was 51.12 a -4.22% decrease of -2.16 from 2019
  • Albireo Pharma Inc Annual EV / Sales (ltm) for 2020 was 53.27 a -0.47% decrease of -0.25 from 2019
  • Albireo Pharma Inc Annual EV / Sales (ltm) for 2020 was 53.53 a -2.49% decrease of -1.33 from 2019
Other Valuation Metrics:
  • Albireo Pharma Inc Market Cap for the quarter ending March 03, 2018 was $387m a 54.85% increase of 213m year over year
  • Albireo Pharma Inc Price / Book for the quarter ending March 03, 2018 was 4.44 a 6.52% increase of 0.29 year over year
  • Albireo Pharma Inc Enterprise Value for the quarter ending March 03, 2018 was $334m a 52.94% increase of 177m year over year
View Chart On Koyfin

Quarterly ALBO EV / Sales (ltm) Data

09/202051.12
09/202053.27
09/202053.53
09/202054.86
09/202054.71
09/202055.09
09/202052.57
09/202051.58
09/202054.15
09/202040.43

Annual ALBO EV / Sales (ltm) Data

202051.12
202053.27
202053.53
202054.86
202054.71
202055.09
202052.57
202051.58
202054.15
202040.43